European Alliance dedicated to accelerating new concepts in HIV vaccine research

The European Commission has granted over 22 million Euros to the European HIV Vaccine Alliance (EHVA) to develop a multidisciplinary platform to evaluate novel preventive and therapeutic vaccines. As partner of the alliance, the Heinrich Pette Institute receives 965,000 Euros from the European Union's Horizon 2020 Research and Innovation Programme. The EHVA is a 5-year project, starting in January 2016. Find more information here. 

More News

The large and lively “HALRIC family” gathered in Lund in February to recap the three amazing years of the project and look ahead to the future. (Photo: HALRIC)
The large and lively “HALRIC family” gathered in Lund in February to recap the three amazing years of the project and look ahead to the future. (Photo: HALRIC)

HALRIC Strengthens Life Science Connections in Northern Europe

After three years, Life Science Nord has issued a positive assessment of the Interreg project HALRIC – Hanseatic Life Science Research Infrastructure Consortium. The project’s ...

Read more …
Dr. Fernando Delgado (CTO), Dr. Michael Hartung (CPO), Alexander Zahn (CEO), and Prof. Dr. Jan Baumbach (CSO) (from left) founded the company in Hamburg in 2025. (Photo: Galagos)
Dr. Fernando Delgado (CTO), Dr. Michael Hartung (CPO), Alexander Zahn (CEO), and Prof. Dr. Jan Baumbach (CSO) (from left) founded the company in Hamburg in 2025. (Photo: Galagos)

#NEWatLSN: Galagos

We are delighted to welcome Galagos as a new member of Life Science Nord e.V.! The founding team answered questions about the company’s initial goals, ...

Read more …
The meetings brought together senior representatives from the European Commission and multiple Member States. (Picture: HALRIC)
The meetings brought together senior representatives from the European Commission and multiple Member States. (Picture: HALRIC)

HALRIC in Brussels

Through direct dialogue with the European Commission and Member States, HALRIC’s Brussels discussions showed how cross-border life science collaboration can unlock efficiency, strengthen European competitiveness, ...

Read more …